Eye (London, England)۲۰۲۴مطالعه مشاهده اینمایه شده در PubMed
Clare Bailey, Manju Chandran, Richard Gale, Nirodhini Narendran, James Talks, Hellen McGoey, Zinab Keshk, Peter Morgan-Warren, Helmut Allmeier, Tobias Machewitz, Praveen J Patel, Deepali Varma
چکیده
The 36-month XTEND (NCT03939767) multicentre, observational, prospective study examined the effectiveness of proactive treatment regimens of intravitreal aflibercept (IVT-AFL) 2 mg in treatment-naïve patients with neovascular age-related macular degeneration (nAMD) in routine clinical practice. The…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1038/s41433-024-03550-y